J. P. Eder - Concepedia

Author

J. P. Eder

Dana-Farber Cancer Institute

Also Known As

J Eder, J P Eder, J. Eder, J. P. Eder, J. Paul Eder, J.P Eder, J.P. Eder, JP Eder

Publications

485

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Brigham and Women's Hospital

About

J. P. Eder is an author at Dana-Farber Cancer Institute specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	299
2	Pathology	4	4	207
3	Health Sciences	2	2	142
4	Immunology	2	2	91
5	Neurology	1	1	18

J. P. Eder

Publications

444

Citations

H-Index

Page 1

	Year	Citations
Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies. D. P. Ryan, Jeffrey G. Supko, J. P. Eder, PubMed Pharmacokinetic StudyPathologyPharmacotherapyRefractory Solid TumorsMetronomic Chemotherapy	2001	116
Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy Lidia Schapira, JH Antin, BJ Ransil, Blood	1990	95
Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo. Beverly A. Teicher, Sylvia A. Holden, J. P. Eder, PubMed Multiple InjectionsImmunologyPharmacotherapyMetronomic ChemotherapyAgent Cytotoxicity	1989	66
A phase I clinical and pharmacokinetic (PK) trial of the aurora kinase (AK) inhibitor MK-0457 in cancer patients Eric H. Rubin, Geoffrey I. Shapiro, Mark N. Stein, Journal of Clinical Oncology PathologyPharmacotherapyCancer PatientsTumor BiologySteady State	2006	48
Phase I trial of escalating pentoxifylline dose with constant dose thiotepa. Bruce J. Dezube, J. P. Eder, ArthurB. Pardee PubMed Therapeutic Drug MonitoringPentoxifylline DoseDrug AnalysisOncologyHealth Sciences	1990	26
Phase I trial of ARQ 501, an Activated Checkpoint Therapy (ACT) agent, in patients with advanced solid tumors Geoffrey I. Shapiro, Jeffrey G. Supko, D. P. Ryan, Journal of Clinical Oncology ImmunologyPathologyPharmacotherapyMetronomic ChemotherapyImmunotherapy	2005	25
Molecular Cloning and Characterization of the Promoter for the Chinese Hamster DNA Topoisomerase IIα Gene Shu‐Wing Ng, J. P. Eder, Lowell E. Schnipper, Journal of Biological Chemistry	1995	22
Glioblastoma multiforme is not a uniform disease! Heather Gilbert, Kagan Ar, F Cassidy, PubMed Neuro-oncologyBrain Tumor BiologyPathologyDiagnostic NeuroradiologyNeurology	1981	18
Endogenous Digoxin-Like Immunoreactive Factor and Digitalislike Factor Associated with the Hypertension of Patients Receiving Multiple Alkylating Agents as Part of Autologous Bone Marrow Transplantation Steven W. Graves, J. P. Eder, S Schryber, Clinical Science	1989	17
Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy Lidia Schapira, JH Antin, BJ Ransil, Blood	1990	11

Page 1